Screener
Avalo Therapeutics AVTX Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by Avalo Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The source filing: Avalo Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001534120-26-000049
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Adjustments to reconcile net cash used in operating activities: | ||
| Depreciation and amortization | 34 | 269 |
| Stock-based compensation | 8,880 | 5,959 |
| Accretion of available-for-sale investments, net | (524) | (146) |
| Change in fair value of contingent consideration | 6,574 | — |
| Contingent consideration paid pursuant to AlmataBio Transaction | (4,813) | — |
| Change in fair value of derivative liability | 530 | 2,150 |
| Deferred taxes | 29 | 24 |
Item 1. Financial Statements.
FAQ
- What is Avalo Therapeutics's accretion (amortization) of discounts and premiums, investments?
- Avalo Therapeutics (AVTX) reported accretion (amortization) of discounts and premiums, investments of $418K in Q2 2026.
- How has Avalo Therapeutics's accretion (amortization) of discounts and premiums, investments changed year-over-year?
- Avalo Therapeutics's accretion (amortization) of discounts and premiums, investments increased by 186.3% year-over-year, from $146K to $418K.
- What does accretion (amortization) of discounts and premiums, investments mean?
- This represents the non-cash adjustment to the carrying value of investment securities held by the company. It reflects the systematic recognition of interest income or expense resulting from the difference between the purchase price and the par value of debt instruments. Investors use this to understand the non-cash components of investment income that impact the company's reported financial performance.
Ask your AI about Avalo Therapeutics's accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude